Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2017 3
2018 1
2019 1
2020 1
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Citations

8 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Awake prone positioning and covid-19.
Verma AA, Razak F, Munshi L, Fralick M. Verma AA, et al. BMJ. 2022 Dec 7;379:o2888. doi: 10.1136/bmj.o2888. BMJ. 2022. PMID: 36740852 No abstract available.
Authors' reply to Fralick and Kesselheim.
Spelsberg A, Keil U, Prugger C. Spelsberg A, et al. BMJ. 2017 Apr 12;357:j1850. doi: 10.1136/bmj.j1850. BMJ. 2017. PMID: 28404584 No abstract available.
Newly prescribed canagliflozin vs. GLP-1 agonists was linked to amputation in older adults with type 2 DM and CVD.
Hao Q, Guyatt G. Hao Q, et al. Ann Intern Med. 2021 Jan;174(1):JC11. doi: 10.7326/ACPJ202101190-011. Epub 2021 Jan 5. Ann Intern Med. 2021. PMID: 33395335
Fralick M, Kim SC, Schneeweiss S, et al. Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study. BMJ. 2020;370:m2812. 32843476....
Fralick M, Kim SC, Schneeweiss S, et al. Risk of amputation with canagliflozin across categories of age and cardiovascular risk in th
Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE).
Fralick M, Colacci M, Munshi L, Venus K, Fidler L, Hussein H, Britto K, Fowler R, da Costa BR, Dhalla I, Dunbar-Yaffe R, Branfield Day L, MacMillan TE, Zipursky J, Carpenter T, Tang T, Cooke A, Hensel R, Bregger M, Gordon A, Worndl E, Go S, Mandelzweig K, Castellucci LA, Tamming D, Razak F, Verma AA; COVID Prone Study Investigators. Fralick M, et al. BMJ. 2022 Mar 23;376:e068585. doi: 10.1136/bmj-2021-068585. BMJ. 2022. PMID: 35321918 Free PMC article. Clinical Trial.
Authors' reply to Scheper and Lijfering.
Fralick M, Juurlink DN. Fralick M, et al. BMJ. 2014 Nov 18;349:g6906. doi: 10.1136/bmj.g6906. BMJ. 2014. PMID: 25406180 No abstract available.
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.
Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, Áinle FN, Alomran F, Alayed K, Alsheef M, AlSumait F, Pompilio CE, Sperlich C, Tangri S, Tang T, Jaksa P, Suryanarayan D, Almarshoodi M, Castellucci LA, James PD, Lillicrap D, Carrier M, Beckett A, Colovos C, Jayakar J, Arsenault MP, Wu C, Doyon K, Andreou ER, Dounaevskaia V, Tseng EK, Lim G, Fralick M, Middeldorp S, Lee AYY, Zuo F, da Costa BR, Thorpe KE, Negri EM, Cushman M, Jüni P; RAPID trial investigators. Sholzberg M, et al. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400. BMJ. 2021. PMID: 34649864 Free PMC article. Clinical Trial.
13 results